Hippo信号对间充质干细胞体外抗氧化应激的影响
该研究为体外实验,使用C57BL/6小鼠来源的骨髓间充质干细胞(mMSCs),经2-脱氧-D-葡萄糖(2-DG)或XMU-MP-1调控Hippo信号,用H2O2诱导氧化应激,通过MTT法和Western Blot检测存活率及Bcl-2/Bax比值。结果显示2-DG(5 mmol/L)激活Hippo信号,XMU-MP-1(100 nmol/L)抑制Hippo信号;H2O2(最低有效浓度0.1 mmol/L)抑制Hippo信号并降低Bcl-2/Bax比值。与0.1 mmol/L H2O2处理相比,2-DG激活Hippo信号使mMSCs存活率从(75.47±9.43)%升至(92.80±9.43)%,XMU-MP-1抑制Hippo信号使存活率降至(57.54±4.59)%。此外,ARDS肺组织条件可显著激活mMSCs中的Hippo信号。结论提示Hippo信号可能通过调节Bcl-2/Bax比值影响mMSCs的存活和抗氧化应激能力。
要点
- 体外实验中,5 mmol/L 2-DG激活Hippo信号(LATS1、p-YAP/YAP、14-3-3均较空白对照组升高,P<0.05)。
- 100 nmol/L XMU-MP-1抑制Hippo信号(LATS1、p-YAP/YAP、14-3-3均较空白对照组降低,P<0.05)。
- H2O2诱导mMSCs死亡的最低有效浓度为0.1 mmol/L,存活率降至(81.25±11.85)%(空白对照组(100.44±12.39)%,P<0.05)。
- 与0.1 mmol/L H2O2处理相比,5 mmol/L 2-DG激活Hippo信号使mMSCs存活率升高至(92.80±9.43)%(H2O2组(75.47±9.43)%,P<0.05),Bcl-2/Bax比值升高至1.14±0.16(H2O2组0.77±0.12,P<0.05)。
- 与0.1 mmol/L H2O2处理相比,100 nmol/L XMU-MP-1抑制Hippo信号使mMSCs存活率降低至(57.54±4.59)%(H2O2组(75.47±9.43)%,P<0.05),Bcl-2/Bax比值降低至0.63±0.20(H2O2组0.77±0.12,P<0.05)。
适用人群与场景
- 体外培养的C57BL/6小鼠骨髓间充质干细胞(mMSCs),经荧光激活细胞分选鉴定并评估成骨、成软骨和成脂分化能力。
处置流程与药物剂量
- 使用2-脱氧-D-葡萄糖(2-DG)5 mmol/L激活Hippo信号,或XMU-MP-1 100 nmol/L抑制Hippo信号处理mMSCs。
- 使用H2O2处理mMSCs诱导氧化应激,最低有效浓度为0.1 mmol/L。
研究设计与关键结果
- 研究类型为体外实验,使用C57BL/6小鼠骨髓间充质干细胞(mMSCs)。
- 2-DG(5 mmol/L)激活Hippo信号:LATS1蛋白灰度值2.33±0.25 vs 空白对照组0.98±0.03,p-YAP/YAP比值2.30±0.35 vs 1.01±0.05,14-3-3蛋白2.19±0.40 vs 0.99±0.04,均P<0.05。
- XMU-MP-1(100 nmol/L)抑制Hippo信号:LATS1蛋白0.69±0.10 vs 空白对照组0.98±0.03,p-YAP/YAP比值0.65±0.06 vs 1.01±0.05,14-3-3蛋白0.75±0.11 vs 0.99±0.04,均P<0.05。
- H2O2诱导mMSCs死亡呈浓度依赖性,最低有效浓度0.1 mmol/L:存活率(81.25±11.85)% vs 空白对照组(100.44±12.39)%,P<0.05。
- H2O2抑制Hippo信号呈浓度依赖性,最低有效浓度0.1 mmol/L:LATS1蛋白0.75±0.06 vs 空白对照组1.01±0.09,p-YAP/YAP比值0.69±0.05 vs 0.98±0.05,均P<0.05;可能与Bcl-2/Bax比值降低有关(0.48±0.18 vs 1.06±0.09,P<0.05)。
- 与0.1 mmol/L H2O2处理相比,5 mmol/L 2-DG激活Hippo信号(LATS1蛋白0.95±0.05 vs 0.64±0.06,p-YAP/YAP比值0.87±0.03 vs 0.45±0.16,均P<0.05)使mMSCs存活率升高至(92.80±9.43)%(H2O2组(75.47±9.43)%,P<0.05),Bcl-2/Bax比值升高至1.14±0.16(H2O2组0.77±0.12,P<0.05)。
- 与0.1 mmol/L H2O2处理相比,100 nmol/L XMU-MP-1抑制Hippo信号(LATS1蛋白0.39±0.03 vs 0.64±0.06,p-YAP/YAP比值0.28±0.04 vs 0.45±0.16,均P<0.05)使mMSCs存活率降低至(57.54±4.59)%(H2O2组(75.47±9.43)%,P<0.05),Bcl-2/Bax比值降低至0.63±0.20(H2O2组0.77±0.12,P<0.05)。
- 与正常肺组织相比,急性呼吸窘迫综合征(ARDS)肺组织条件显著激活mMSCs中的Hippo信号:LATS1蛋白1.71±0.08 vs 1.00±0.10,p-YAP/YAP比值2.46±0.39 vs 1.01±0.04,14-3-3蛋白2.27±0.52 vs 1.01±0.08,均P<0.05。
证据类型、等级与局限
- 证据类型:体外实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该体外实验提示Hippo信号可能通过调节Bcl-2/Bax比值影响小鼠骨髓间充质干细胞在氧化应激下的存活,尚不能直接转化为急诊或ICU临床做法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the effects of Hippo signaling on anti-oxidative stress of mouse marrow mesenchymal stem cells (mMSCs) in vitro.
METHODS: mMSCs derived from C57BL/6 mice were identified using fluorescence-activated cell sorting analysis and the capabilities of osteogenic, chondrogenic and adipogenic differentiation were evaluated. 2-deoxy-D-glucose (2-DG) or XMU-MP-1 was used to modulate Hippo signaling. Oxidative stress was induced by H2O2 treatment and the effect of oxidative stress induced by H2O2 on survival of mMSCs was evaluated using methyl thiazolyl tetrazolium (MTT) assay. The effect of oxidative stress induced by H2O2 on Hippo signaling and the effect of Hippo signaling on capability of anti-oxidative stress of mMSCs were analyzed through apoptosis-regulated proteins (Bcl-2 and Bax) using Western Blot.
RESULTS: Hippo signaling was activated by 2-DG in a concentration-dependent manner and the effect was most prominent by 5 mmol/L of 2-DG [compared with the blank control group, large tumor suppressor 1 (LATS1) protein (grey value): 2.33±0.25 vs. 0.98±0.03, phosphorylated Yes-associated protein (p-YAP)/YAP protein ratio (grey value): 2.30±0.35 vs. 1.01±0.05, 14-3-3 protein (grey value): 2.19±0.40 vs. 0.99±0.04, all P < 0.05]; Hippo signaling was inhibited by 100 nmol/L of XMU-MP-1 [compared with the blank control group, LATS1 protein (grey value): 0.69±0.10 vs. 0.98±0.03, p-YAP/YAP protein ratio (grey value): 0.65±0.06 vs. 1.01±0.05, 14-3-3 protein (grey value): 0.75±0.11 vs. 0.99±0.04, all P < 0.05]. Death of mMSCs was induced by H2O2 in a concentration-dependent manner and the minimal effective concentration was 0.1 mmol/L [compared with the blank control group, survival rate of mMSCs: (81.25±11.85)% vs. (100.44±12.39)%, P < 0.05]. Inhibition of Hippo signaling was induced by H2O2 in a concentration-dependent manner and the minimal effective concentration was also 0.1 mmol/L [compared with the blank control group, LATS1 protein (grey value): 0.75±0.06 vs. 1.01±0.09, p-YAP/YAP protein ratio (grey value): 0.69±0.05 vs. 0.98±0.05, both P < 0.05], those effects might associate with reduction of Bcl-2/Bax ratio (grey value: 0.48±0.18 vs. 1.06±0.09, P < 0.05). Compared with the treatment of 0.1 mmol/L of H2O2, activation of Hippo signaling by 5 mmol/L of 2-DG [LATS1 protein (grey value): 0.95±0.05 vs. 0.64±0.06, p-YAP/YAP protein ratio (grey value): 0.87±0.03 vs. 0.45±0.16, both P < 0.05] improved survival of mMSCs [(92.80±9.43)% vs. (75.47±9.43)%, P < 0.05] through an increase of Bcl-2/Bax ratio (grey value: 1.14±0.16 vs. 0.77±0.12, P < 0.05); however, inhibition of Hippo signaling by 100 nmol/L of XMU-MP-1 [LATS1 protein (grey value): 0.39±0.03 vs. 0.64±0.06, p-YAP/YAP protein ratio (grey value): 0.28±0.04 vs. 0.45±0.16, both P < 0.05] decreased survival of mMSCs [(57.54±4.59)% vs. (75.47±9.43)%, P < 0.05] through an decrease of Bcl-2/Bax ratio (grey value: 0.63±0.20 vs. 0.77±0.12, P < 0.05). Compared with normal lung tissue, acute respiratory distress syndrome (ARDS) lung tissue markedly activate Hippo signaling in mMSCs [LATS1 protein (grey value): 1.71±0.08 vs. 1.00±0.10, p-YAP/YAP protein ratio (grey value): 2.46±0.39 vs. 1.01±0.04, 14-3-3 protein (grey value): 2.27±0.52 vs. 1.01±0.08, all P < 0.05].
CONCLUSIONS: Hippo signaling could affect survival and capability of anti-oxidative stress of mMSCs via modulation of Bcl-2/Bax ratio in vitro.
参考来源
- Li L, Dong L, Hui J, et al. [Effects of Hippo signaling on anti-oxidative stress of mesenchymal stem cells in vitro]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29663987. doi:10.3760/cma.j.issn.2095-4352.2018.04.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。